Addtech Life Science

Addtech Life Science's net sales were SEK 1,141 million (1,002), a 14 percent increase. Operating profit amounted to SEK 108 million (98). With a good final quarter, the business area for the first time achieved a full-year operating profit in excess of SEK 100 million. The growth in sales and profit came from a combination of solid organic growth and strategic acquisitions. Demand for diagnostic equipment and reagents from the Nordic healthcare sector was upbeat throughout the entire financial year. The market for measuring and analysis instruments for the Nordic process industry remained unchanged during the year, although the fourth quarter was weaker because of shifts in deliveries in certain projects. The market for equipment for Nordic healthcare and research laboratories, which was stable during the year, ended with a strong final quarter with several substantial instrument sales. 

During the year the business area carried out three acquisitions, of Leica Nilomark OY, Active Care Sverup AB and Norsk Analyse AS.

Download Excel

Addtech Life Science
2012/2013 2011/2012
Net sales, SEKm 1,141 1,002
Operating profit, SEKm 108 98
Operating margin, % 9.5 9.8
Working capital year average, SEKm 147 121
Return on working capital (P/WC), % 74 81
Investments in property, plant and equipment, SEKm 9 14
Average number of employees 347 299